Movatterモバイル変換

Doxercalciferol

From Wikipedia, the free encyclopedia

(Redirected fromHectorol)

Doxercalciferol
Names

IUPAC name (1S,3R,5Z,7E,22E)-9,10-Secoergosta-5,7,10,22-tetraene-1,3-diol
Other names 1-Hydroxyergocalciferol; 1-Hydroxyvitamin D2; 1α-Hydroxyergocalciferol; 1α-Hydroxyvitamin D2; Hectorol; TSA 840
Identifiers
CAS Number	54573-75-0^Y
3D model (JSmol)	Interactive image
ChEBI	CHEBI:4712
ChEMBL	ChEMBL1200810^N
ChemSpider	4444554^Y
DrugBank	DB06410^N
ECHA InfoCard	100.170.997
IUPHAR/BPS	2790
PubChem CID	5281107
UNII	3DIZ9LF5Y9^Y
CompTox Dashboard(EPA)	DTXSID1034214
InChI InChI=1S/C28H44O2/c1-18(2)19(3)9-10-20(4)25-13-14-26-22(8-7-15-28(25,26)6)11-12-23-16-24(29)17-27(30)21(23)5/h9-12,18-20,24-27,29-30H,5,7-8,13-17H2,1-4,6H3/b10-9+,22-11+,23-12-/t19-,20+,24+,25+,26-,27-,28+/m0/s1^Y Key: HKXBNHCUPKIYDM-CGMHZMFXSA-N^Y InChI=1/C28H44O2/c1-18(2)19(3)9-10-20(4)25-13-14-26-22(8-7-15-28(25,26)6)11-12-23-16-24(29)17-27(30)21(23)5/h9-12,18-20,24-27,29-30H,5,7-8,13-17H2,1-4,6H3/b10-9+,22-11+,23-12-/t19-,20+,24+,25+,26-,27-,28+/m0/s1 Key: HKXBNHCUPKIYDM-CGMHZMFXBN
SMILES O[C@@H]1CC(\C(=C)[C@@H](O)C1)=C\C=C2/CCC[C@]3([C@H]2CC[C@@H]3[C@@H](/C=C/[C@H](C)C(C)C)C)C
Properties
Chemical formula	C₂₈H₄₄O₂
Molar mass	412.658 g·mol⁻¹
Pharmacology
ATC code	H05BX03 (WHO)
Except where otherwise noted, data are given for materials in theirstandard state (at 25 °C [77 °F], 100 kPa). N verify (what is ^YN ?) Infobox references

Chemical compound

Doxercalciferol (or1-hydroxyergocalciferol, trade nameHectorol) is drug forsecondary hyperparathyroidism andmetabolic bone disease.^[1] It is a synthetic analog ofergocalciferol (vitamin D₂). It suppressesparathyroid synthesis and secretion.^[2]

Doxercalciferol is the vitamin D₂ analogue ofalfacalcidol.^[3] It undergoes 25-hydroxylation in theliver to become the activeercalcitriol, without the involvement of kidneys.^[4]

References

[edit]

^Sprague S M; Ho L T (2002). "Oral doxercalciferol therapy for secondary hyperparathyroidism in a peritoneal dialysis patient".Clinical Nephrology.58 (2):155–160.doi:10.5414/cnp58155.PMID 12227689.
^"Doxercalciferol". Drugs.com.
^Upton, R. A.; Knutson, J. C.; Bishop, C. W.; LeVan, L. W. (1 April 2003)."Pharmacokinetics of doxercalciferol, a new vitamin D analogue that lowers parathyroid hormone".Nephrology Dialysis Transplantation.18 (4):750–758.doi:10.1093/ndt/gfg030.PMID 12637645.
^"HECTOROL INJECTION (doxercalciferol)"(PDF).FDA accessdata. Retrieved21 April 2018.

Calcium homeostasis (H05)

Parathyroid hormone and analogues

Anti-parathyroid hormone agents

Calcitonin derivatives	Calcitonin Elcatonin
Calcimimetics	Cinacalcet Etelcalcetide
Other	Calcifediol Calcitriol Cholecalciferol Cinacalcet Doxercalciferol Ergocalciferol Etelcalcetide Evocalcet Paricalcitol

v t e Vitamin D receptor modulators
VDRTooltip Vitamin D receptor	Agonists:7-Dehydrocholesterol 25-Hydroxyergocalciferol Alfacalcidol Calcifediol Calciferol Calcipotriol Calcitriol Cholecalciferol (vitamin D₃) Dihydrotachysterol Doxercalciferol EB-1089 Eldecalcitol Ercalcidiol Ercalcitriol Ergocalciferol (vitamin D₂) Lithocholic acid Maxacalcitol Paricalcitol Tacalcitol Antagonists:ZK159222 TEI-9647
See also Receptor/signaling modulators

Thishormonal preparation article is astub. You can help Wikipedia byexpanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Doxercalciferol&oldid=1225080583"

Categories:

Hidden categories:

[8]ページ先頭